Table 3.
Univariate regression analysis of the dependency of recanalization times.
| Explanatory Variable (Predictor) | ODT | ONT | DNT | OGT | DGT | |||
|---|---|---|---|---|---|---|---|---|
| IVT Only Group (N = 398) |
EVT (±IVT) Group (N = 411) |
IVT Only Group (N = 398) |
EVT (±IVT) Group (N = 411) |
IVT Only Group (N = 398) |
EVT (±IVT) Group (N = 411) |
EVT (±IVT) Group (N = 411) |
EVT (±IVT) Group (N = 411) |
|
| Age, (years) | −0.0050 (0.0026); 0.076 | −0.0021 (0.0030); 0.8174 | −0.0034 (0.0022); 0.125 | 0.0025 (0.0019); 0.197 | 6.215 × 10−5 (1.558 × 10−3); 0.968 | 0.0060 (0.0028); 0.0312 | −0.0004 (0.0018); 0.798 | 0.0042 (0.0021); 0.0476 |
| Male sex | −0.00007 (0.0661); 0.999 | −0.2142 (0.0751); 0.0517 | 0.0207 (0.0573); 0.718 | −0.0428 (0.0484); 0.377 | −0.0134 (0.0395); 0.734 | 0.0314 (0.0676); 0.642 | −0.1325 (0.0477); 0.0058 | 0.0275 (0.0553); 0.619 |
| NIHSS baseline | −0.0270 (0.0065); 0.0006 | −0.0111 (0.0068); 0.3363 | −0.0174 (0.0057); 0.0027 | −0.0033 (0.0049); 0.495 | −0.0052 (0.0038); 0.178 | 0.0045 (0.0063); 0.474 | −0.0047 (0.0041); 0.249 | 0.0026 (0.0047); 0.581 |
| Posterior vascular territory | 0.3190 (0.0927); 0.0021 | 0.2141 (0.1325); 0.3363 | 0.284 (0.0808); 0.0005 | 0.1889 (0.0866); 0.0304 | 0.1063 (0.0579); 0.0672 | 0.1701 (0.1277); 0.184 | 0.2232 (0.0791); 0.0051 | 0.1729 (0.0852); 0.0433 |
| Clinical symptoms | ||||||||
| Limb weakness (HEMIPAR) |
−0.1927 (0.0785); 0.0271 | −0.0868 (0.1662); 0.8278 | −0.1673 (0.0681); 0.0146 | −0.1384 (0.1328); 0.298 | −0.0655 (0.0479); 0.173 | 0.0930 (0.1680); 0.58 | −0.2052 (0.1081); 0.0585 | −0.1231 (0.1217); 0.312 |
| Drooping of the mouth corner (N VII) |
−0.1554 (0.0712); 0.0486 | −0.1816 (0.1060); 0.3363 | −0.1619 (0.0619); 0.0093 | −0.1678 (0.0694); 0.0165 | −0.0669 (0.0431); 0.122 | −0.1952 (0.0976); 0.0469 | −0.0674 (0.0640); 0.293 | −0.2539 (0.0763); 0.0009 |
| Speech difficulties (SPEECH) |
−0.2164 (0.0758); 0.0100 | 0.0069 (0.1155); 0.9530 | −0.2275 (0.0662); 0.0006 | −0.0366 (0.0714); 0.609 | −0.1063 (0.0471); 0.0247 | −0.0525 (0.1000); 0.6 | −0.0752 (0.0675); 0.266 | −0.099 (0.0767); 0.198 |
| Sensory impairment (SENSATION) |
0.0039 (0.0887); 0.9990 | 0.4925 (0.1955); 0.0909 | 0.0624 (0.0781); 0.424 | −0.0707 (0.1121); 0.529 | −0.0197 (0.0538); 0.715 | 0.0250 (0.2233); 0.911 | 0.2102 (0.1080); 0.0526 | −0.1226 (0.1248); 0.327 |
| Visual problems (VISION) |
0.3724 (0.1180); 0.0046 | 0.2739 (0.2404); 0.5632 | 0.2694 (0.1039); 0.0099 | 0.1271 (0.1565); 0.418 | 0.0840 (0.0757); 0.268 | −0.0596 (0.2491); 0.811 | 0.2008 (0.1466); 0.172 | 0.2197 (0.1513); 0.148 |
| VERTIGO | 0.37064 (0.1037); 0.0019 | 0.3421 (0.2625); 0.5335 | 0.3434 (0.0923); 0.0002 | −0.0913 (0.1746); 0.602 | 0.1410 (0.0661); 0.0337 | 0.2770 (0.2484); 0.266 | 0.1908 (0.1688); 0.259 | 0.1165 (0.1744); 0.504 |
| HEADACHE | 0.2488 (0.1623); 0.1638 | −0.1691 (0.5841); 0.8939 | 0.238 (0.1447); 0.101 | −0.1183 (0.3468); 0.733 | 0.0359 (0.0970); 0.711 | −0.2124 (0.4945); 0.668 | −0.3638 (0.4105); 0.376 | 0.0696 (0.3666); 0.85 |
| Nausea and/or 666 vomiting (VOMIT) |
0.4029 (0.1135); 0.0019 | 0.1496 (0.2408); 0.8278 | 0.357 (0.1012); 0.0004 | 0.3517 (0.1547); 0.0241 | 0.1181 (0.0731); 0.107 | 0.1613 (0.2041); 0.43 | 0.0456 (0.1692); 0.787 | 0.2319 (0.1844); 0.209 |
| Loss of consciousness (COMA) |
−0.2572 (0.4077); 0.6252 | −0.0876 (0.1662); 0.8278 | 0.0447 (0.3643); 0.902 | 0.2309 (0.1237); 0.0636 | 0.3891 (0.2192); 0.0767 | 0.4960 (0.1745); 0.0049 | 0.1814 (0.0992); 0.0685 | 0.2670 (0.1181); 0.0244 |
| Occlusion | ||||||||
| ICAe | N/A | −0.0803 (0.1091); 0.8174 | N/A | −0.0622 (0.0692); 0.37 | N/A | −0.0011 (0.0971); 0.991 | −0.0035 (0.0713); 0.96 | −0.1015 (0.0865); 0.242 |
| ICAi | N/A | −0.0085 (0.0991); 0.9530 | N/A | −0.0300 (0.0657); 0.648 | N/A | 0.0887 (0.0880); 0.315 | −0.0481 (0.0657); 0.465 | 0.0743 (0.0740); 0.315 |
| MCA/M1 | N/A | −0.0175 (0.0860); 0.9229 | N/A | −0.1082 (0.0554); 0.0524 | N/A | −0.0994 (0.0789); 0.209 | −0.1132 (0.0533); 0.0346 | −0.1206 (0.0608); 0.0481 |
| MCA/M2 | N/A | −0.1073 (0.1091); 0.654 | N/A | 0.0470 (0.0703); 0.504 | N/A | 0.0536 (0.1000); 0.593 | −0.0132 (0.0690); 0.848 | 0.0660 (0.0815); 0.418 |
| ACA | N/A | −0.3067 (0.2627); 0.5632 | N/A | −0.2934 (0.1736); 0.0925 | N/A | 0.1950 (0.2229); 0.383 | −0.1851 (0.1689); 0.274 | 0.0331 (0.1848); 0.858 |
| PCA | N/A | 0.0849 (0.2410); 0.8861 | N/A | 0.3438 (0.1548); 0.0275 | N/A | 0.2230 (0.2228); 0.318 | 0.1866 (0.1565); 0.234 | 0.2837 (0.1576); 0.0727 |
| VA | N/A | −0.1268 (0.2938); 0.8632 | N/A | 0.0970 (0.1565); 0.536 | N/A | 0.4025 (0.2476); 0.106 | 0.0744 (0.1691); 0.66 | 0.1508 (0.1656); 0.363 |
| BA | N/A | 0.3080 (0.1542); 0.2580 | N/A | 0.1902 (0.1114); 0.0894 | N/A | 0.0554 (0.1598); 0.729 | 0.2578 (0.0916); 0.0052 | 0.1518 (0.1049); 0.149 |
| IVT | N/A | −0.4410 (0.0798); <0.0001 | N/A | N/A | N/A | N/A | −0.0089 (0.0518); 0.863 | −0.1019 (0.0572); 0.0757 |
Outputs from univariate regression models (OLS) for log transformed dependent variable (time intervals) are reported as follows: beta (SE); p value; ACA, anterior cerebral artery; BA, basilar artery; DGT, door-to-groin time; DNT, door-to-needle time; EVT, endovascular therapy; iCAe, extracranial internal carotid artery; ICAi, intracranial internal carotid artery; IVT, intravenous thrombolysis; MCA/M1, M1 segment of the middle cerebral artery; MCA/M2, M2 segment of the middle cerebral artery; N, number of patients; N/A, not applicable; NIHSS, National Institutes of Health Stroke Scale; ODT, onset-to-door time; OGT, onset-to-groin time; ONT, onset-to-needle time; PCA, posterior cerebral artery; SE, standard error; VA, vertebral artery.